Attorneys representing dozens of plaintiffs who suffered nerve damage after taking the drugs Levaquin, Avelox or Cipro have asked a judge in Philadelphia, Pennsylvania to consolidate the cases. The three drugs are part of a class of antibiotics known as fluoroquinolones or FQ antibiotics, which have been linked by the Food and Drug Administration to an increase risk of peripheral neuropathy, a type of nerve damage occurring in the extremities.
FQ antibiotics are some of the most commonly prescribed drugs in the U.S., accounting for 27 million prescriptions in 2011 alone. However, a warning by the FDA has linked FQs to an increased risk of nerve damage in the arms, hands, legs, or feet, which is known as peripheral neuropathy.
Lawyers representing the Philadelphia plaintiffs have asked the judge overseeing the lawsuits to consolidate the 32 cases they have filed into a single mass tort program. The attorneys say that they expect to file an additional 30 lawsuits against Bayer and Janssen Pharmaceuticals, the drug companies that manufactured the FQ antibiotic drugs involved in the lawsuits.
The Philadelphia lawsuits against Bayer and Janssen allege that the drugmakers failed to properly warn patients about the link between using FQ antibiotics and peripheral neuropathy. Although FQs have carried warnings about the possibility of peripheral neuropathy for over a decade, the lawsuits allege that these warnings falsely claim that the risk of nerve damage for these drugs was “rare” and that symptoms would stop if patients discontinued use of the drugs. In fact, the lawsuits allege, nerve damage caused by FQ antibiotics is far more common than the warnings stated and is often permanent, even if patients discontinue use.
Hundreds of lawsuits have been filed by patients who developed peripheral neuropathy after taking Levaquin, Avelox, Cipro, or other FQ antibiotics. In addition to the dozens of cases that have been filed in Pennsylvania, the manufacturers of these medications are facing about 200 lawsuits that were transferred to a federal multidistrict litigation (or MDL) in the U.S. District Court for the District of Minnesota in August 2015.
Fluoroquinolones Users with Nerve Damage May Qualify to File a Lawsuit
Patients who developed peripheral neuropathy after taking Levaquin, Cipro, Avelox, or other FQ antibiotics antibiotics may be eligible to file a lawsuit. The first step in taking legal action is to consult with an attorney with the knowledge and experience in pharmaceutical liability litigation to help guide you through the process of filing a case.
The lawyers at Heygood, Orr & Pearson have represented hundreds of individuals who have been harmed by dangerous prescription drugs, including the fentanyl pain patch, Yaz birth control, Actos, Avandia, and Accutane. Our attorneys have amassed years of trial experience on behalf of our clients, working to ensure that they receive the compensation they deserve for the negligence and other wrongful actions of the pharmaceutical industry.
The lawyers at Heygood, Orr & Pearson have based their careers around the idea that the manufacturers of defective drugs and dangerous medical devices should be held responsible for their actions. Far too often, the pharmaceutical industry puts its own profits ahead of the interests of patients, disregarding the safety of individuals who may use their products because of the enormous sales these drugs and medical devices may generate. At Heygood, Orr & Pearson, we believe that when the actions of drug companies and medical devices manufacturers compromise the health and safety of their patients, they should be held accountable in a court of law.
If you or a loved one has been diagnosed with peripheral neuropathy after taking FQ antibiotics such as Levaquin, Cipro, or Avelox, contact Heygood, Orr & Pearson to learn more about your legal options. For a free legal consultation from our attorneys, please call us toll-free at 1-877-446-9001. You can also reach us by following the link to our free case evaluation form and answering a few simple questions about your case to get started.